BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288


SEARCH JOBS




Industry
Diagnostics






 Company News
NanoString Technologies Inc. (NSTG) To Release Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 4, 2014 10/10/2014 7:16:29 AM
NanoString Technologies Inc. (NSTG) Collaborates With Brigham and Women's Hospital In Boston To Accelerate Translation Of Genomic Discoveries Into Clinical Diagnostics In Oncology 10/7/2014 10:25:01 AM
NanoString Technologies Inc. (NSTG) Introduces Novel Gene Expression Panel For Immuno-Oncology Research 9/10/2014 11:36:58 AM
NanoString Technologies Inc. (NSTG) Announces Unexpected Death Of Chief Medical Officer, J. Wayne Cowens, MD 8/27/2014 8:30:44 AM
NanoString Technologies Inc. (NSTG) To Present At Upcoming Investor Conferences 8/21/2014 8:14:20 AM
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014 10:05:49 AM
NanoString Technologies Inc. (NSTG) Releases Financial Results For Second Quarter Of 2014 8/5/2014 3:18:16 PM
NanoString Technologies Inc. (NSTG) Introduces New Universal Junction Probe Design For Detecting Gene Fusions 7/29/2014 10:10:00 AM
NanoString Technologies Inc. (NSTG), Celgene Corporation (CELG) Strike $45 Million Companion Diagnostic Pact 6/3/2014 5:00:15 PM
NanoString Technologies Inc. (NSTG) Receives Canadian Market Approval For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 5/7/2014 8:42:05 AM
123456789